RTW

Neurogastrx Secures $60 Million in Series B Financing and Expands Management Team to Advance Its Pipeline of Transformative Investigational Therapies for Gastrointestinal Disorders

Retrieved on: 
Thursday, August 26, 2021
Health, Other Science, Research, Pharmaceutical, Science, Biotechnology, Gastroesophageal reflux disease, Drug development, Investment, Global marketing, Venture, Series, Boehringer Ingelheim, Diabetes, Merck, PPI, RTW, Doctor of Philosophy, State, Therapy, Biogen, AstraZeneca, EE, CFO, Multimedia, Bluebird bio, Patient, Partnership, Gastroparesis, Daewoong Pharmaceutical, Enzyme inhibitor, Stomach, Roche, GI, Ironwood Pharmaceuticals, GERD, D2, MD, Pharmaceutical industry

Neurogastrx, Inc., a privately held specialty pharmaceutical company developing transformative therapies for gastrointestinal (GI) disorders, announced today the successful completion of a $60 million Series B crossover round led by Vivo Capital.

Key Points: 
  • Neurogastrx, Inc., a privately held specialty pharmaceutical company developing transformative therapies for gastrointestinal (GI) disorders, announced today the successful completion of a $60 million Series B crossover round led by Vivo Capital.
  • This pipeline includes fexuprazan for the treatment of erosive esophagitis (EE) and NG101 for the treatment of gastroparesis.
  • EE impacts 20 percent of the 65 million people in the U.S. who have gastroesophageal reflux disease (GERD), and gastroparesis impacts as many as 10 million Americans.
  • In conjunction with the Series B crossover and in preparation for a pivotal growth phase for the company, Neurogastrx is expanding its management team with three new hires.

Majesco Launches Majesco ClaimVantage Connect Digital Portal

Retrieved on: 
Tuesday, August 10, 2021
Professional Services, Data Management, Other Professional Services, Technology, Other Technology, Insurance, Software, Cloud, Software as a service, RTW, TPA, MGA, Product management, Technology, P&C, Digital, Solution, Generation Z, SVP, Navigation, L&H, Financial services, Research, Insurance, General manager, Salesforce, Leadership, VP, Millennials, Online shopping

Majesco , a global leader of cloud insurance software solutions for insurance business transformation, today announced the launch of Majesco ClaimVantage Connect , a new digital portal specific for customers using Majesco ClaimVantage solutions including claims, absence and accommodation management.

Key Points: 
  • Majesco , a global leader of cloud insurance software solutions for insurance business transformation, today announced the launch of Majesco ClaimVantage Connect , a new digital portal specific for customers using Majesco ClaimVantage solutions including claims, absence and accommodation management.
  • Majesco ClaimVantage Connect will enable our customers to connect and engage with their customers 24/7, empowering them to access real-time updates when its convenient for them.
  • As Gen Z and Millennials become the primary insurance-buying cohort, insurers must meet the expectations of todays digital consumer, and Majesco ClaimVantage Connect enables insurers and TPAs to deliver that modern experience.
  • Majesco ClaimVantage Connect can be seamlessly used with Majesco ClaimVantage Claims Management Software for L&H, Majesco Absence Management , Majesco IDAM and Majesco Accommodation Management .

ReEmployAbility® Successfully Completes SOC® 2 Type 1 Examination, Reinforcing its Commitment to Data Security

Retrieved on: 
Tuesday, July 20, 2021
Regulation, Standards, Sarbanes–Oxley Act, Auditing, HITRUST, System and Organization Controls, Payment Card Industry Data Security Standard, Data security, Uday Ali Pabrai

BRANDON, Fla., July 20, 2021 /PRNewswire-PRWeb/ --ReEmployAbility, the largest national provider of early return-to-work (RTW) services and transitional employment, today announced that it has successfully a completed SOC 2 Type 1 Service Organization Controls (SOC) examination.

Key Points: 
  • BRANDON, Fla., July 20, 2021 /PRNewswire-PRWeb/ --ReEmployAbility, the largest national provider of early return-to-work (RTW) services and transitional employment, today announced that it has successfully a completed SOC 2 Type 1 Service Organization Controls (SOC) examination.
  • The examination affirms ReEmployAbility's long-standing commitment to data security practices and its customers that trust ReEmployAbility to secure, control, and efficiently manage their sensitive PII and program data.
  • Torres continued, "obtaining the SOC 2 report in addition to reaffirming and improving our practices and standards will remain a priority of ReEmployAbility.
  • Services provided include SOC 1, SOC 2, SOC 3, SOC for Cybersecurity, CSA STAR, HIPAA/HITECH, ISO 27001, CMMC, PCI-DSS, HITRUST CSF, Microsoft SSPA Attestation, Penetration Testing, GDPR, CCPA and more.

Sequoia Consulting Group Launches The Return to Work Center with Partners One Medical and Wilson Sonsini’s SixFifty

Retrieved on: 
Thursday, May 14, 2020
Legal, Software, Human resources, General Health, Health, Consulting, Professional services, Technology, RTW, Workplace, RTW PlaceRite Alternative Return-To-Work, Sequoia Consulting Group, One Medical, SixFifty

Sequoia Consulting Group , a tech-enabled consulting and services company, today announced a software solution called the Sequoia Return to Work Center.

Key Points: 
  • Sequoia Consulting Group , a tech-enabled consulting and services company, today announced a software solution called the Sequoia Return to Work Center.
  • The Return to Work (RTW) Center helps companies successfully manage the transition back to a healthy and productive workplace during this unprecedented crisis.
  • The RTW Center integrates services and content from healthcare provider One Medical and law firm Wilson Sonsinis SixFifty to create a holistic approach to reopening the workplace.
  • We believe software solutions like the Return to Work Center are needed as a standard for employers in the new world of work.